4.1 Article

Perspectives of pediatric oncologists and palliative care physicians on the therapeutic use of cannabis in children with cancer

Journal

CANCER REPORTS
Volume 5, Issue 9, Pages -

Publisher

WILEY
DOI: 10.1002/cnr2.1551

Keywords

cancer; cannabidiol; cannabis; pediatrics; symptom control; tetrahydrocannabinol

Categories

Funding

  1. Canadian Cancer Society [707031]
  2. Canadian Institutes of Health Research

Ask authors/readers for more resources

Most pediatric oncologists and palliative care physicians recognize a potential role for cannabis in symptom control in children with cancer, although only a small number believe cannabis may be beneficial for cancer itself. They desire more information about dosing, side effects, and safety of cannabis, and emphasize the importance of research on cannabis for symptom relief.
Background Children with cancer are increasingly using cannabis therapeutically. Aim The purpose of this study was to determine the perspectives and practices of pediatric oncologists and palliative care physicians regarding the use of cannabis for medical purposes among children with cancer. Methods A self-administered, voluntary, cross-sectional, deidentified online survey was sent to all pediatric oncologists and palliative care physicians in Canada between June and August 2020. Survey domains included education, knowledge, and concerns about cannabis, views on its effectiveness, and the importance of cannabis-related research. Data were analyzed using descriptive statistics. Results In total, 122/259 (47.1%) physicians completed the survey. Although 62.2% of the physicians completed some form of training about medical cannabis, nearly all (95.8%) desired to know more about the dosing, side effects, and safety of cannabis. Physicians identified a potential role of cannabis in the management of nausea and vomiting (85.7%), chronic pain (72.3%), cachexia/poor appetite (67.2%), and anxiety or depression (42.9%). Only four (0.3%) physicians recognized cannabis to be potentially useful as an anticancer agent. Nearly all physicians reported that cannabis-related research for symptom relief is essential (91.5%) in pediatric oncology, whereas 51.7% expressed that future studies are necessary to determine the anticancer effects of cannabis. Conclusions Our findings indicate that most pediatric oncologists and palliative care physicians recognize a potential role for cannabis in symptom control in children with cancer. Well-conducted studies are required to create evidence for cannabis use and promote shared decision making with pediatric oncology patients and their caregivers.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.1
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available